0001209191-17-024676.txt : 20170404 0001209191-17-024676.hdr.sgml : 20170404 20170404160723 ACCESSION NUMBER: 0001209191-17-024676 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170403 FILED AS OF DATE: 20170404 DATE AS OF CHANGE: 20170404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203435077 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-731-8389 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT, STE #250 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hatfield Jeffrey S. CENTRAL INDEX KEY: 0001609879 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 17738164 MAIL ADDRESS: STREET 1: 11080 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-03 0 0001339970 aTYR PHARMA INC LIFE 0001609879 Hatfield Jeffrey S. C/O ATYR PHARMA, INC. 3545 JOHN HOPKINS COURT, SUITE 250 SAN DIEGO CA 92121 1 0 0 0 Stock Option (right to buy) 3.50 2017-04-03 4 A 0 32000 0.00 A 2027-04-03 Common Stock 32000 32000 D The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning May 3, 2017, such that this option will be fully exercisable on April 3, 2020, subject to the recipient's continued service on the Issuer's Board of Directors. Nancy D. Krueger, Attorney-In-Fact 2017-04-04